Article

Mennini, F. S., Costa, S., Favato, G. and Picardo, M. (2009) Anti-HPV vaccination: a review of recent economic data for Italy. Vaccine, 27 (1). A54-A61. ISSN 0264-410X doi: https://doi.org/10.1016/j.vaccine.2009.02.052

Stewart, J.-A., Day, M., Print, C. and Favato, G. (2009) Compliance in the supply chain: implications of Sarbanes-Oxley for UK businesses. The IUP Journal of Supply Chain Management, 6 (1). pp. 7-19. ISSN 0972-9267

Mamarbachi, R., Day, M. and Favato, G. (2009) Evaluating art as an alternative investment asset. Journal of Financial Transformation, 24. pp. 61-71. ISSN 1755-361X

Favato, G., Mariani, P., Print, C., Capone, A., Pelagatti, M., Pieri, V., Marcobelli, A., Tragni, E., Trotta, M.G., Zucchi, A. and Catapano, A.L. (2008) Effetto dei fabbisogni terapeutici sesso ed età correlati sui costi di prescrizione nella medicina generale: Il modello di analisi ASSET (Age and sex standardised estimates of treatment). PharmacoEconomics - Italian Research Articles, 10 (2). pp. 89-98. ISSN 2035-6137 doi: https://doi.org/10.2165/00136178-200810020-00003

Favato, G. and Print, C. (2008) Real investment options: a case illustration. Management Online Review. pp. 1-12. ISSN 1996-3300

Favato, G. (2008) Rilevanza delle variazioni demografiche di farmaco-utilizzazione per il governo della spesa farmaceutica pubblica. Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione, 1 (2). pp. 22-28. ISSN 1974-4633

Favato, G., Mariani, P., Mills, R.W., Capone, A., Pelagatti, M., Pieri, V., Marcobelli, A., Trotta, M., Zucchi, A. and Catapano, A. (2007) ASSET (Age/Sex Standardised Estimates of Treatment): a research model to improve the governance of prescribing funds in Italy. PLoS ONE, 2 (7). e592. ISSN 1932-6203 doi: https://doi.org/10.1371/journal.pone.0000592

Favato, G., Mills, R.W. and Pieri, V. (2007) Analisi costo-efficacia del programma di vaccinazione anti-HPV in Italia: il modello multi-coorte Markov. Farmaci: Aggiornamenti per il medico pratico, 31 (Supp. 2). pp. 1-14.

Favato, G., Mills, R.W. and Weinstein, B. (2007) Estimating the cost of clinical innovation: parametric analysis of late stage pharmaceutical R&D. International Journal of Technology Intelligence and Planning, 3 (3). pp. 233-245. ISSN 1740-2840 doi: https://doi.org/10.1504/IJTIP.2007.015771

Favato, G. and Mills, R. (2007) Identifying best practices in cost management. Henley Manager Update, 18 (3). pp. 43-52. ISSN 1745-7866

Favato, G. and Mills, R.W. (2006) Challenging conventional wisdom in R&D. Henley Manager Update, 18 (1). pp. 55-64. ISSN 1745-7866

Mills, R., Weinstein, B. and Favato, G. (2006) Using scenario thinking to make real options relevant to managers: a case illustration. Journal of General Management, 31 (3). pp. 49-74. ISSN 0306-3070

Book or Report Section

Favato, G. (2009) Consortium stretches the limits of hostile takeover. In: Bonham, A. and Langdon, K. (eds.) Finance. Fast track to success. Pearson Education Limited, Harlow, pp. 112-114. ISBN 9780273721789

Favato, G. (2009) Value drivers of corporate deals. In: Bonham, A. and Langdon, K. (eds.) Finance. Fast track to success. Pearson Education Limited, Harlow, pp. 131-132. ISBN 9780273721789

Report

Favato, G., (2008) Relevance of real options to corporate investment decisions. Working Paper. Social Science Research Network (SSRN) pp20.

Mamarbachi, R., Day, M. and Favato, G., (2008) Art as an alternative investment asset. Working Paper. Social Science Research Network (SSRN) pp22.

Favato, G., Mariani, P., Print, C., Capone, A., Pelagatti, M., Pieri, V., Marcobelli, A., Tragni, E., Trotta, M.G., Zucchi, A. and Catapano, A.L., (2008) Knowledge-based governance can improve the elderly population's equity of access to public pharmaceutical funding: the ASSET (age/sex standardised estimates of treatment) research model. Working Paper. Social Science Research Network (SSRN) pp9.

Favato, G., (2008) Consortium strategy: stretching the limits of hostile takeovers. Working Paper. Social Science Research Network (SSRN) pp11.

Favato, G., Print, C., Mills, R. and Weinstein, B., (2008) Estimating the direct costs of developing new drugs. Working Paper. Henley Management College, Henley on Thames. ISBN 9781861612933

Conference or Workshop Item

Favato, G. (2009) Hypolipidemic agents in chronic therapy: a compliance study in the Italian ASSET cohort (INV-70). In: 2nd Pharmscifair, 8-12 Jun, Nice, France.

Favato, G. (2009) Long term sustainability of SSN pharmaceutical coverage in Italy: a twenty year outlook (2005-2025). In: III Congresso Nazionale SITeCS, Naples, Italy.

Book

Favato, G. and Print, C. (2008) Corporate finance decisions in volatile economic times. iUniverse. ISBN 9780595524136